Subject: Agrylin and ES (fwd)
Date: Mon, 6 Apr 1998 102312 -0500 (CDT)
From: "Roy L. Beavers" <rbeavers@llion.org>
To: emfguru@hotmail.com
--------------------------------------------------
Hi everybody:
Interesting question below ... especially to me, for the reason that I
discuss following Valdemar's message.....
Cheerio....
Roy Beavers (EMFguru)
rbeavers@llion.org..............http://www.feb.se/EMF-L/EMF-L.html
................................It is better to light a single candle ...
than to curse the darkness...............................................
---------- Forwarded message ----------
Date: Mon, 6 Apr 1998 12:57:56 +0000
From: Valdemar Gisli Valdemarsson
To: rbeavers@llion.org
Subject: Agrylin and ES
Hi Roy.
I would like to know if anyone is familiar with the medicine AGRYLIN.
(anagrelide hydrochloride) Agrylin is a new medicine prescribed to treat
patients with Essential Thrombocythemia to lower the count of platelet in
the blood.
I ask because one ET-patient contacted me and described side effects which
I found extreemly similiar to electric sensitivity. In information brocure
about the medicine, which is produced by Roberts Pharmaceutical
Corporation, it is informed that most common side effects include headache,
fast heartbeat, diarrhea, weakness, pain in the abdomen, nausea, dizziness
and shortness of breath.
What is most interesting is that this patient livies near by a LW masts and
TV/FM tower. Her surroundings are highly saturated with RF waves. Since
she started to take this medicine she can't tolerate to go out for a walk
in her neigborhood. Every time she walks she feels something like electric
pulses in her feets. She is also feeling stress and tension. But when she
goes for a stroll far away from the tower she does not feel those symtoms.
The stress and tension is less and this electric pulse in her feet is not a
problem.
In the brochure it is stated that side effects can be; for the whole body
system,: Fever, flu symtoms, chils, neck pain and photosensitivity.
HOW IT Works:
Anagrelide is a quinazoline derivative that is structurally similar to
ketanserin (an antiaggregant and antihypertensive), methaqualone (a central
nervous system depressant, metolazone (an antihypertensive saluretic), and
prazosin (an antihypertensive. It is a powerful platelet antiaggregant. It
appears to inhibit cyclic nucleotide phospholisterase and the release of
arachidonic acid from phospholipase, possibly by inhibiting phospholipase.
It also causes a dose-related reduction in platelet production, which
results from decreased megakaryocyte hypermaturation. The drug disrupts the
postmitotic phase of maturation.
Is it possible that this medicine also triggers Electric Sensitivity?
Valdemar Gisli Valdemarsson
Iceland
Phone: 354-896-6110
email: vgv@isholf.is
Internet: http://www.isholf.is/vgv
***********************************************************************
Valdemar:
I'm sure you realize we are again in the "anecdotal info" arena.
As I have said before, some of these anecdotal experiences need to
be checked out. Science often gets its ideas from such experiences.
I have often wondered if it is just legend that the apple fell on
the head of one prescient observor (Newton) who consequently discovered
gravity -- an anecdotal experience....
Nevertheless, for many years I have harbored a suspicion that
thrombocythemia (TC), itself, has origins in the EMF exposure
experience.
I have personal knowledge of a case of a young woman who worked
in an "underground" environment for nearly two years at one of Great
Britain's major communication centers -- with "all kinds" of
communications equipment there, including Britain's most powerful long
range radio transmitters of that time. (Shortly after WW II and during
the Suez crisis.) She worked shifts of 8-12 hours or sometimes around the
clock.
Within a year or two thereafter, she became aware of health problems she
could not explain or understand. Frequent abcesses in soft tissue,
sudden unexplained vomiting and abdominal pain which caused the British
doctors, at first, to diagnose appendicitis -- never confirmed. The
British doctor told her "she should never offer to give blood," but he did
not tell her why or what the diagnosis was. (Many doctors assume such
"godly" ... "you don't need to know" stances toward their patients -- in
America as well as Britain.) One of her (later) most aggravating symptoms
was "itchiness" (within the blood vessels and throughout the body) at
night with a resultant inability to sleep.... Which she sometimes
experiences to this day. She now exists on a daily regimen of 250 mg
aspirin. Her platelet count is still far too high, but the aspirin may be
keeping her alive.
She believes that the "itchiness" condition, when it occurs, is lessened
by antihistamines. That is something she has discovered for herself.
It was never prescribed.
Years later, she was diagnosed with TC by an American doctor. She
believes that this condition had its origins at the time of her early
job in the communications center. She was then 17-18.
Only some 5 or 6 years ago did she begin to understand the properties
of EMF exposure ... and rationally connect the two, EMF and her chronic
illness.....
TC is not taken very seriously in the U.S. The standard treatment is
to start you on aspirin and tell you that you have 15 years (on average)
to live. Doctors have told her that it is usual for TC to progress into
leukemia or polycythemia, both of which are more health threatening.
The young lady above (my dear wife) has outlived the prognosis ...
but through the years she has had a number of serious health problems,
which she believes derived, in part, from her TC blood condition and
perhaps a resultant depressed immune condition. (I will not even "try" to
explain the connection we "think" we see with the immune system and the TC
condition....)
Thanks for your message, Valdemar. Let's see if we can get some
better, non-anecdotal, answers from "out there" somewhere in cyberspace...
Cheerio....
Roy Beavers (EMFguru)
rbeavers@llion.org
Archive provided courtesy of WaveGuide, http://www.wave-guide.org
Reprinted with permission of Roy Beavers, http://www.feb.se/EMF-L/EMF-L.html